Methods of activating enzyme breakers

Patent metadata

Field	Value
Publication number	US-2017349818-A1
Application number	US-201615174049-A
Country	US
Kind code	A1
Filing date	Jun 6, 2016
Priority date	Jun 6, 2016
Publication date	Dec 7, 2017
Grant date	—

Abstract

A well treatment fluid is disclosed containing water, a crosslinkable component, a crosslinker; and an enzyme breaker containing a cellulase enzyme, the well treatment fluid having a total dissolved solids content of at least about 75,000 mg/L up to about 250,000 mg/L. A method of treating a subterranean formation is also disclosed including placing the well treatment fluid in the subterranean formation. It is also disclosed that the well treatment fluid can be a combination of a first fluid including water, the crosslinkable component, the crosslinker, and the enzyme breaker, and having a total dissolved content A with formation water having a total dissolved content B which is higher than the total dissolved content A of the first fluid.

First claim

What is claimed is:

1 . A method of treating a subterranean formation, the method comprising:
a) providing a well treatment fluid comprising water, a crosslinkable component, a crosslinker and an enzyme breaker comprising a cellulase enzyme; wherein the treatment fluid attains a temperature T 1 from about 125° F. to about 275° F., has an initial pH from about 4.5 to about 8, a total dissolved solids content of at least about 75,000 mg/L up to about 250,000 mg/L, and an initial viscosity greater than about 150 cP measured at the temperature T 1 and at a shear rate of 100 s −1 ; b) placing the well treatment fluid into the subterranean formation; and c) wherein the viscosity of the well treatment fluid after about 2 hours from placement in the subterranean formation is below about 100 cP measured at the temperature of use and at a shear rate of 100 s −1 .

2 . The method of claim 1 wherein the cellulase enzyme is selected from the group consisting of pyrolase enzyme, encapsulated pyrolase HT enzyme, pyrolase HT enzyme, fraczyme enzyme, and combinations thereof.

3 . The method of claim 2 wherein the cellulase enzyme is pyrolase HT enzyme.

4 . The method of claim 3 wherein the crosslinkable component is selected from the group consisting of guar, CMHPG, and combinations thereof.

5 . The method of claim 4 wherein the crosslinkable component is guar.

6 . The method of claim 4 wherein the crosslinker comprises a metal component selected from the group consisting of zirconium, titanium and aluminum.

7 . The method of claim 4 wherein the enzyme breaker is encapsulated with an encapsulating material.

8 . The method of claim 7 wherein the encapsulating material comprises an acid-precursor.

9 . The method of claim 6 wherein the metal component of the crosslinker is present in the well treatment fluid in an amount of from about 10 to about 200 ppm, based on the total weight of the well treatment fluid.

10 . The method of claim 9 wherein the cellulase enzyme is present in the well treatment fluid in an amount of from about 0.0001 to about 0.03 wt %, based on the total weight of the well treatment fluid.

11 . The method of claim 10 wherein the crosslinkable component is present in the well treatment fluid in an amount of from about 0.1 to about 0.72 wt %, based on the total weight of the well treatment fluid.

12 . A well treatment fluid comprising:
a) water; b) a crosslinkable component; c) a crosslinker; and d) an enzyme breaker comprising a cellulase enzyme; wherein the well treatment fluid has a total dissolved solids content of at least about 75,000 mg/L up to about 250,000 mg/L, a pH from about 4.5 to about 8, and a viscosity greater than about 150 cP measured at the temperature of use and at a shear rate of 100 s −1 .

13 . The well treatment fluid of claim 12 wherein the cellulase enzyme is selected from the group consisting of pyrolase enzyme, pyrolase HT enzyme, encapsulated pyrolase HT enzyme, fraczyme enzyme, and combinations thereof.

14 . The well treatment fluid of claim 13 wherein the crosslinkable component is selected from the group consisting of guar, CMHPG, and combinations thereof.

15 . The well treatment fluid of claim 14 wherein the crosslinker comprises a metal component selected from the group consisting of zirconium, titanium and aluminum.

16 . The well treatment fluid of claim 15 wherein the cellulase enzyme is present in the well treatment fluid in an amount of from about 0.0001 to about 0.03 wt %, based on the total weight of the well treatment fluid; the crosslinkable component is present in the well treatment fluid in an amount of from about 0.1 to about 0.72 wt %, based on the total weight of the well treatment fluid; and the metal component of the crosslinker is present in the well treatment fluid in an amount of from about 10 to about 200 ppm, based on the total weight of the well treatment fluid.

17 . A method of treating a subterranean formation, the method comprising:
a) providing a first fluid comprising water, a crosslinkable component, a crosslinker, and an enzyme breaker comprising a cellulase enzyme, wherein the first fluid has a total dissolved content A; b) placing the first fluid into the subterranean formation comprising an aqueous formation fluid having a total dissolved content B which is higher than the total dissolved content A of the first fluid; c) combining the first fluid with the aqueous formation fluid in the subterranean formation to form a well treatment fluid, wherein the well treatment fluid attains a temperature T 1 from about 125° F. to about 275° F., has an initial pH from about 4.5 to about 8, a total dissolved solids content of at least about 75,000 mg/L up to about 250,000 mg/L, and an initial viscosity greater than about 150 cP measured at the temperature T 1 and at a shear rate of 100 s −1 ; d) wherein the viscosity of the well treatment fluid after about 2 hours from forming in the subterranean formation is below about 100 cP measured at the temperature of use and at a shear rate of 100 s −1 .

18 . The method of claim 17 wherein the cellulase enzyme is selected from the group consisting of pyrolase enzyme, pyrolase HT enzyme, encapsulated pyrolase HT enzyme, fraczyme enzyme, and combinations thereof.

19 . The method of claim 18 wherein the crosslinker comprises a metal component selected from the group consisting of zirconium, titanium and aluminum.

20 . The method of claim 19 wherein the enzyme breaker is encapsulated with an encapsulating material.

Assignees

• Schlumberger Technology Corp

Inventors

• Mirakyan Andrey
• Meza Camille
• Hutchins Richard Donald

Classifications

• C09K8/887

  containing cross-linking agents · CPC title

• C09K2208/24

  Bacteria or enzyme containing gel breakers · CPC title

• C09K8/685

  containing cross-linking agents · CPC title

• C09K8/706 Primary

  Encapsulated breakers · CPC title

• E21B43/267

  reinforcing fractures by propping · CPC title